Molecular target testing in a preclinical culture assay of Emery Dreifuss muscular dystrophy

Emery Dreifuss 肌营养不良症临床前培养测定中的分子靶点测试

• 批准号: 466912
• 负责人: Gorospe Kristyna A
• 金额: $ 1.27万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-12-01 至 2022-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=466912&lang=en
• 关键词: Cell Therapy; Emery Dreifuss Muscular Dystrophy; Endogenous Repair; In Vitro Assay; Linc Complex; Muscle Stem Cells; Musculoskeletal Models; Regenerative Medicine; Skeletal Muscle Regeneration; Tissue Engineering

An emerging strategy of regenerative medicine focuses on harnessing the function of resident stem cell populations to heal tissue injuries and cure disease, a process called endogenous repair. For instance, in cases of major muscle damage such as muscular

再生医学的新兴策略侧重于利用常驻干细胞群的功能来治愈组织损伤和治愈疾病，这一过程称为内源性修复。例如，在严重肌肉损伤的情况下，例如肌肉损伤